logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Filgotinib CAS 848416-07-9

Filgotinib CAS 848416-07-9

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 848416-07-9

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
848416-07-9
Appearance::
White To Off-white Solid
Molecular Formula::
C21H24F3N3O4
Molecular Weight::
439.42800
EINECS NO::
NA
MDL NO::
NA
CAS NO::
848416-07-9
Appearance::
White To Off-white Solid
Molecular Formula::
C21H24F3N3O4
Molecular Weight::
439.42800
EINECS NO::
NA
MDL NO::
NA
Filgotinib CAS 848416-07-9

Product Description:

Product Name: filgotinib CAS NO: 848416-07-9

 

 

 

Synonyms:

KRP-AM1977X;

3-Quinolinecarboxylicacid,7-[(3S,4S)-3-[(cyclopropylamino)methyl]-4-fluoro-1-pyrrolidinyl]-6-fluoro-1-(2-fluoroethyl)-1,4-dihydro-8-methox y-4-oxo-

 

 

 

Chemical & Physical Properties:

Appearance: Solid

Assay :≥98.0%

Density: 1.4±0.1 g/cm3

Boiling Point: 637.0±55.0℃ at 760 mmHg

Flash Point: 339.0±31.5℃

Exact Mass: 439.171906

Vapour Pressure: 0.0±2.0 mmHg at 25℃

Index of Refraction: 1.605

Storage: 0-4℃ for short term (days to weeks), or -20℃ for long term (months)

 

 

 

KRP-AM1977Xis a potent and orally active fluoroquinolone antibacterial agent. filgotinib potently inhibits infections caused by various pathogens, including quinolone-resistant strains. Lascufloxacin has the potential for various infectious diseases treatment, including lower respiratory tract infections[1][2].

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.